Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis
Top Cited Papers
Open Access
- 30 September 2013
- journal article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 132 (3), 593-600.e12
- https://doi.org/10.1016/j.jaci.2013.04.005
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Increased expression of CC chemokine ligand 18 in patients with chronic rhinosinusitis with nasal polypsJournal of Allergy and Clinical Immunology, 2012
- Common variants at 5q22 associate with pediatric eosinophilic esophagitisNature Genetics, 2010
- Dexamethasone and FK506 Inhibit Expression of Distinct Subsets of Chemokines in Human Mast CellsThe Journal of Immunology, 2009
- Epithelium, Inflammation, and Immunity in the Upper Airways of Humans: Studies in Chronic RhinosinusitisProceedings of the American Thoracic Society, 2009
- Perspectives on the Etiology of Chronic Rhinosinusitis: An Immune Barrier HypothesisAmerican Journal of Rhinology, 2008
- Evidence of a role for B cell–activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polypsJournal of Allergy and Clinical Immunology, 2008
- Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunityCurrent Opinion in Immunology, 2007
- Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cellsThe Journal of Experimental Medicine, 2007
- Furin at the cutting edge: From protein traffic to embryogenesis and diseaseNature Reviews Molecular Cell Biology, 2002
- Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLPNature Immunology, 2002